mRNA technology + history of vaccine development

FACT SHEET FOR RECIPIENTS AND CAREGIVERS EMERGENCY USE AUTHORIZATION (EUA) OF THE MODERNA COVID-19 VACCINE TO PREVENT CORONAVIRUS DISEASE 2019 (COVID-19) IN INDIVIDUALS 18 YEARS OF AGE AND OLDER

PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery

The spike protein of SARS-CoV–a target for vaccine and therapeutic development

mRNA Vaccine Era—Mechanisms, Drug Platform and Clinical Prospection

PAMAM dendrimers as promising nanocarriers for RNAi therapeutics

Engineers design programmable RNA vaccines

Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTechmRNA COVID‐19 vaccine

Without these lipid shells, there would be no mRNA vaccines for COVID-19

Understanding mRNA COVID-19 Vaccines

Developing mRNA-vaccine technologies